[Skip to content]

.
Portrait of Andy Parrett

The Evolution of Outsourcing Contract Management Coming of Age

Andy Parrett

Keywords

Contract management, Outsourcing, Standard operating procedures (SOPs)


 

The contract management role in clinical development outsourcing is still a relatively young profession. It was conceived in response to the rationalisation of pharmaceutical company workforces and the rise of the CROs and, given that these developments have been ongoing for only around thirty years, we should not be surprised that contract management remains an emerging discipline.

As it stands today, the nature of the role can vary significantly between pharmaceutical companies. In small companies the idea of a dedicated contract management resource may seem like an expensive luxury, such that clinical operations personnel undertake their own outsourcing activities in what procurement professionals might call ‘end-user purchasing’. Many large companies, meanwhile, have witnessed their contract management teams grow from embryonic end-user beginnings into cost-sensitive resource management functions, often closely aligned to, or merged with, an established company procurement team.

For me, however, the most exciting developments in the role are occurring in today’s small to mid-sized companies; for it is in companies where enough growth has occurred already to invest resource in developing contract management solutions, but enough flexibility remains to adopt contemporary best practices, that the real advances are being driven. Thus, Contract Managers at mid-sized companies or committed end-users at small companies are often leading the way in determining the next steps in developing the profession. We have seen this trend at the Pharmaceutical Contract Management Group (www.pcmg.org.uk), which celebrates its fifteenth birthday this year.

The PCMG as a catalyst for change

The PCMG was initially established in response to the frustrations of perceived poor service provision, and its early members had a primary agenda to share intelligence on the CROs they were using. However, the vision of the organisation changed rapidly to one of providing a forum for developing best practice outsourcing solutions. Those members with the time and flexibility to adopt the lessons learned within the PCMG forum have therefore found themselves (perhaps by accident) at the vanguard of defining a new profession and making the role a necessity, not a luxury, in clinical development outsourced projects. The key word there is ‘projects’…

Enlarge ImageCRfocus 20(07) Parrett fig 1
Figure 1 Evolution of the Contract Manager role.
I mentioned that large companies often take the step of merging or aligning their clinical contract management team with their existing procurement function. Handled well, this can benefit the organisation at least through achieving a centralised oversight of purchasing activities. Handled badly, however, it can result in too much emphasis on savings at the point of transaction because that is often at the heart of what procurement teams are used to deliver. Services for projects, especially big projects with joint teams and multiple stakeholders such as those in clinical development as distinct from, say, manufacturing, aren’t something you can purchase like that. There is too much uncertainty around scope, responsibilities, outcomes and relationships to orchestrate certain and meaningful cost savings at the point of purchase. At the PCMG we have realised this for some time and so the spotlight for best practice in this forum has gradually shifted away from tools and processes focused solely upon CRO selection, cost negotiation and contract execution to include areas where the Contract Manager can add value after the ink has dried. Despite its name, therefore, this has made the PCMG an organisation just as relevant to operational personnel who work routinely with CROs as Contract Managers themselves. Meanwhile, we have witnessed the Contract Manager role evolve from one with interests in operational delivery to one without and then back again (Figure 1).

This reengagement of interests in post-contract operational delivery shouldn’t be considered a backward step. It does not reduce the Contract Manager’s ability to fulfil his/her front-end contracting responsibilities; it enhances it. For when a Contract Manager shares accountability for delivery, rather than just ‘throwing it over the fence’, he/she will care more about getting the right CRO and right contract in place up-front.
Enlarge ImageCRfocus 20(07) Parrett figure 2
Figure 2 Processes of the Modern Contract Manager.

Development of SOPs

While catalysed by the PCMG, the evolution of the Contract Manager role has been a natural one. For many companies it may have begun with the ‘Early Contract Manager’ establishing two new processes: one for outsourcing and one for contracting. In Figure 2, I’ve given these processes the arbitrary names Vendor Bidding SOP and Contract Management SOP respectively. I’ve heard it argued that, as long as ICH GCP requirements for the allocation of responsibilities are captured somewhere in operational or QA SOPs, then documented processes for the Contract Manager activities aren’t needed. This is lazy thinking: successful organisations document their processes wherever they add value. Think of SOPs like a cookbook: while an experienced chef may deliver very successfully without one, the novice needs a recipe to refer to. Mistakes get made when the operator lacks the experience or the instructions to follow and this logic applies just as readily to the activities of a Contract Manager as a CRA or a Study Manager.

Figure 2 Processes of the Modern Contract Manager.
Following the establishment of the first two SOPs, the natural course for the evolution of best practices is to remain focused on pre-contract activities to begin with. CRO ‘qualification’ SOPs (yellow in Figure 2) should ideally be separated out from ‘selection’ SOPs (pink), such that while QA and senior management stakeholders may play a role in determining which CROs are placed onto an Approved Vendor List (AVL), it remains the decision of operational stakeholders as to which particular CROs are initially considered and subsequently awarded work. Further, the PCMG has seen a trend over the past 5 years where the Contract Manager is increasingly surrendering his/her decision-making rights in both qualification and selection processes to become solely a facilitator. I would recommend this approach as best practice.

So far, so good but, as already mentioned, to really add value the ‘Modern Contract Manager’ must provide services beyond the execution of the contract. To some extent, it is likely that the Early Contract Manager is already dipping his/her toes into the water here, perhaps taking responsibility for invoice management and change order development. These are the germinal activities of a Project Scope Management SOP, which should describe what tools will be applied to forecast spend and track payments and how the Contract Manager will liaise regularly with the Study Manager to review scope and timelines against the contract. The proper application of a tool such as a Forecast Earned Value & Invoice Tracker (FEVIT) can enable accurate monthly snapshots of spend versus milestone payments so that accruals can be assessed and budgets controlled. (If you would like a free copy of a generic FEVIT spreadsheet tool for your company, please contact me.)

The establishment of a Project Scope Management SOP inevitably provides a forum for more regular communication with the Study Manager on CRO performance issues and thus plants the seed for the development of the final process presented in Figure 2: Relationship Management. The key elements of this process include the development of a system for collecting performance and relationship metrics and enabling conflict deterrence and continuous learning. The process feeds back into a number of the established processes, as indicated by the arrows in Figure 2, which show how the set of processes connect with each other throughout the vendor management lifecycle.

Relational contracting

It is fitting that the final piece in the evolution of the process jigsaw for the Modern Day Contract Manager is a Relationship Management SOP, because by the time it is in place he/she has become a true ‘relational contracting specialist’. This is quite a different animal from the traditional procurement professional, whose focus has historically been purchasing commodities and generating savings at the point of transaction. Relational contracting represents an understanding that project risks cannot be outsourced but must be managed by the sponsor through the application of project management methodologies contained within the processes I have described. This engenders a ‘total cost of ownership’ philosophy that shifts focus onto minimising cost throughout the lifecycle of spend rather than just in up-front negotiations.

I have mentioned that in recent years some large pharmaceutical companies have seen their clinical development contract management teams merge with their traditional procurement functions and this is likely to be an increasing trend in the future. The precise structure and policies surviving each departmental merger will vary between companies and, sadly, will probably depend more on the people and politics involved in each case than any sensible rationalisation, to begin with at least. However, such a merger can be positive provided that the relational approach that has evolved out of clinical development outsourcing teams is allowed to persist and flourish.

A model consisting of a centralised sourcing department, responsible for global, transactional purchasing and limited oversight of hubs conducting local, relational purchasing is, in my view, the best practice solution for pharma procurement functions and should represent the most likely future working environment of the Contract Manager in clinical development outsourcing. It is reassuring to think such a future holds a vital part to play for the still emerging Contract Manager role and further exciting prospects for the PCMG in both driving and reflecting the development of a very valuable and rewarding profession.


Portrait of Andy Parrett

Andy Parrett (andrew.parrett@btinternet.com) is Chairman of the Pharmaceutical Contract Management Group (PCMG).

Investors in People
The premier organisation for professionals in all aspects of clinical research